Organic Letters
Letter
(6)(a)Kwon,O.;Park,S.B.;Schreiber,S.L.J.Am.Chem.Soc.2002,124,
13402. (b)Ko, S.K.;Jang, H.J.;Kim, E.;Park, S.B. Chem. Commun.2006,
2962.(c)Wyatt,E.E.;Fergus,S.;Galloway,W.R.J.D.;Bender,A.;Fox,D.
J.; Plowright, A. T.; Jessiman, A. S.; Welch, M.; Spring, D. R. Chem.
Commun. 2006, 3296.
prolonged heating. This provides further evidence for the
formation of an N-acyliminium ion intermediate in this process,
as opposed to a cyclic amine derivative derived from the trapping
of a linear imine intermediate via a Pictet−Spengler cyclization.
In conclusion, we have developed a highly efficient, metal-free,
workup-free microwave-assisted branching cascades strategy to
generate skeletally diverse 3,4-dihydroquinazolinone-embedded
polyheterocyclic scaffolds in a one-pot operation. This protocol
offersarapidanddirectapproachtogeneratealibraryofmorethan
50 polyfunctionalized polyheterocyclic DHQs bearing 12 distinct
scaffolds in excellent yields, starting from readily available and
stableo-formylcarbamateprecursorswithabroadsubstratescope.
We have also described successful strategies for preparation of
second-generation libraries through functionalization of the
DHQ scaffold. Mechanistic investigations of the cascade
cyclization confirmed the intermediacy of an N-acyliminium ion
intermediate and led to the discovery of a solvent-controlled
process for directing the reaction through an intra- or
intermolecular cyclization cascade sequence. Thus, this reaction
manifold allows access to an enormous range of diverse DHQ
derivatives covering novel chemical space, and further inves-
tigations to explore the biological activity of these compounds are
underway in our laboratory.
(7)(a)Oguri,H.;Schreiber,S.L.Org.Lett.2005,7,47.(b)Burke,M.D.;
Schreiber, S. L. Angew. Chem., Int. Ed. 2004, 43, 46.
(8) (a) Ascic, E.; Le Quement, S. T.; Ishoey, M.; Daugaard, M.; Nielsen,
T. E. ACS Comb. Sci. 2012, 14, 253. (b) Luo, T.; Schreiber, S. L. J. Am.
Chem. Soc. 2009, 131, 5667. (c) Nielsen, T. E.; Schreiber, S. L. Angew.
Chem., Int. Ed. 2008, 47, 48.
(9)Rolfe, A.;Lushington, G. H.;Hanson, P.R. Org. Biomol.Chem. 2010,
8, 2198.
(10) (a) Hung, W.; Ramek, A.; Wang, Y.; Kaya, T.; Wilson, J.; Clemons,
P.;Young,D.W.Proc.Natl.Acad.Sci.U.S.A.2011,108,6799.(b)Murray,
C. W.;Rees, D. C. Nat. Chem. 2009, 1, 187. (c)Hajduk, P. J.;Greer, J. Nat.
Rev. Drug Discovery 2007, 6, 211.
(11)(a)Sharada, D.S.;Shinde,A.H.;Patel,S.M.;Vidyacharan,S. J.Org.
Chem. 2016, 81, 6463. (b) Patil, N. T.; Bansode, A. H.; Chimala, P.
(12) (a) Liu, W.; Khedkar, V.; Baskar, B.; Schurmann, M.; Kumar, K.
̈
Angew. Chem., Int. Ed. 2011, 50, 6900. (b)Murali, A.;Medda, F.; Winkler,
M.; Giordanetto, F.; Kumar, K. Bioorg. Med. Chem. 2015, 23, 2656.
(13) Garcia-Castro, M.; Kremer, L.;Reinkemeier, C. D.; Unkelbach, C.;
Strohmann, C.; Ziegler, S.; Ostermann, C.; Kumar, K. Nat. Commun.
2015, 6, 6516.
(14) Robbins, D.; Newton, A. F.;Gignoux, C.;Legeay, J.-C.; Sinclair, A.;
Rejzek,M.;Laxon,C.A.;Yalamanchili,S.K.;Lewis,W.;O’Connell,M.A.;
Stockman, R. A. Chem. Sci. 2011, 2, 2232.
(15) Bansode, A. H.; Shaikh, A. C.; Kavthe, R. D.; Thorat, S.; Gonnade,
R. G.; Patil, N. T. Chem. - Eur. J. 2015, 21, 2319.
ASSOCIATED CONTENT
* Supporting Information
TheSupportingInformationisavailablefreeofchargeontheACS
■
S
(16) Patil, N. T.; Shinde, V. S.; Sridhar, B. Angew. Chem., Int. Ed. 2013,
52, 2251.
Full experimental details and characterization data (PDF)
(17) Patil, N. T.; Konala, A.; Sravanti, S.; Singh, A.; Ummanni, R.;
Sridhar, B. Chem. Commun. 2013, 49, 10109.
(18) Morton, D.; Leach, S.; Cordier, C.; Warriner, S.; Nelson, A. Angew.
Chem., Int. Ed. 2009, 48, 104.
(19) Sawant, R. T.; Stevenson, J.; Odell, L. R.; Arvidsson, P. I.
Tetrahedron: Asymmetry 2013, 24, 134.
AUTHOR INFORMATION
Corresponding Author
■
Notes
(20) (a) Stevens, M. Y.; Wieckowski, K.; Wu, P.; Sawant, R. T.;Odell, L.
R. Org. Biomol. Chem. 2015, 13, 2044. (b) Sawant, R. T.; Stevens, M. Y.;
Odell,L.R.Eur.J.Org.Chem.2015,2015,7743.(c)Sawant,R.T.;Stevens,
M. Y.; Odell, L. R. Molbank 2015, 2015, M866.
(21)(a)Corbett,J.W.;Ko,S.S.;Rodgers,J.D.;Gearhart, L.A.;Magnus,
N. A.; Bacheler, L. T.; Diamond, S.; Jeffrey, S.; Klabe, R. M.; Cordova, B.
C.; Garber, S.; Logue, K.; Trainor, G. L.; Anderson, P. S.; Erickson-
Viitanen,S.K.J.Med.Chem.2000,43,2019.(b)Barrow,J.C.;Rittle,K.E.;
Reger, T. S.; Yang, Z.-Q.; Bondiskey, P.; McGaughey, G. B.; Bock, M. G.;
Hartman, G. D.; Tang, C.; Ballard, J.; Kuo, Y.; Prueksaritanont, T.; Nuss,
C.E.;Doran,S.M.;Fox,S.V.;Garson,S.L.;Kraus,R.L.;Li,Y.;Marino,M.
J.;KuzmickGraufelds,V.;Uebele,V.N.;Renger,J.J.ACSMed.Chem.Lett.
2010, 1, 75.
(22) (a) Maryanoff, B. E.; Zhang, H.; Cohen, J. H.; Turchi, I. J.;
Maryanoff, C. A. Chem. Rev. 2004, 104, 1431. (b) Speckamp, W. N.;
Moolenaar, M. J. Tetrahedron 2000, 56, 3817. (c) Yazici, A.; Pyne, S.
Synthesis 2009, 2009, 339. (d) Yazici, A.; Pyne, S. Synthesis 2009, 2009,
513.
(23) (a) Diness, F.; Beyer, J.; Meldal, M. Chem. - Eur. J. 2006, 12, 8056.
(b) Kano, S.; Yuasa, Y.; Shibuya, S. Synthesis 1984, 1984, 1071. (c) Klein,
G.; Ostresh, J. M.; Nefzi, A. Tetrahedron Lett. 2003, 44, 2211.
(24)(a)Hasegawa,H.;Muraoka,M.;Matsui,K.;Kojima,A.Bioorg.Med.
Chem. Lett. 2006, 16, 727. (b) Hasegawa, H.; Muraoka, M.; Matsui, K.;
Kojima, A. Bioorg. Med. Chem. Lett. 2003, 13, 3471.
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
This research was supported by Uppsala University and we thank
Dr. Lisa Haigh (Imperial College London) and Dr. Anatoly Mish-
nev (Latvian Institute of Organic Synthesis) for assistance with
accurate mass and X-ray structure determination.
REFERENCES
■
(1) (a) Li, J.; Ballmer, S. G.; Gillis, E. P.; Fujii, S.; Schmidt, M. J.;
Palazzolo, A. M. E.; Lehmann, J. W.; Morehouse, G. F.; Burke, M. D.
Science2015, 347, 1221. (b)Galloway, W. R. J. D.;Stokes, J. E.; Spring, D.
R. Small Molecule Medicinal Chemistry; John Wiley & Sons, Inc.: 2015; pp
77−101. (c) Stockwell, B. R. Nature 2004, 432, 846. (d) Tavassoli, A.;
Hamilton, A. D.; Spring, D. R. Chem. Soc. Rev. 2011, 40, 4269.
(2) Galloway, W. R. J. D.;Diaz
R. Angew. Chem., Int. Ed. 2009, 48, 1194.
́ ́
-Gavilan, M.;Isidro-Llobet, A.;Spring, D.
(3) Schreiber, S. L. Science 2000, 287, 1964.
(4) (a) Grabowski, K.; Baringhaus, K.-H.; Schneider, G. Nat. Prod. Rep.
2008, 25, 892. (b) Kaiser, M.; Wetzel, S.; Kumar, K.; Waldmann, H. Cell.
Mol. Life Sci. 2008, 65, 1186. (c) Lenci, E.; Guarna, A.; Trabocchi, A.
Molecules2014,19,16506.(d)Spring,D.R.Chem.Soc.Rev.2005,34,472.
(e)Dobson, C. M. Nature2004, 432, 824.(f)Thomas, G. L.;Wyatt, E. E.;
Spring,D. R. Curr. Opin. DrugDiscoveryDevel. 2006,9,700. (g)Spring,D.
R. Org. Biomol. Chem. 2003, 1, 3867. (h) Garcia-Castro, M.;
Zimmermann, S.; Sankar, M. G.; Kumar, K. Angew. Chem., Int. Ed.
2016, 55, 7586.
(25) CCDC 1473149 contains the crystallographic data for 33a.
(26) CCDC 1473153 contains the crystallographic data for 35b′.
(27) Arend, M.; Westermann, B.; Risch, N. Angew. Chem., Int. Ed. 1998,
37, 1044.
(28) Pictet, A.; Spengler, T. Ber. Dtsch. Chem. Ges. 1911, 44, 2030.
(5) Dandapani, S.; Marcaurelle, L. A. Curr. Opin. Chem. Biol. 2010, 14,
362.
D
Org. Lett. XXXX, XXX, XXX−XXX